Back to search
Left-Sided Heart Failure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Left-Sided Heart Failure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Left-Sided Heart Failure trials you may qualify forHeart failure is a severe disease affecting approximately 1-2% of the adult population in developed countries and around 26 million people worldwide. Up to 10%…
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥…
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mi…
Background There are significant limitations in the current approaches to assessing 2 important areas of cardiovascular physiology - the systemic circulation an…
This study will compare two different methods to pace the heart to treat heart failure including: 1. The current standard method of implanting a pacing lead in…
The goal of this clinical trial is to investigate the impact of repetitive acute Cyclosporine A (CsA) bolus therapy in patients suffering from TTS with an eleva…
The main purpose of this study is to observe outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in heart failure (HF) patients with left ventricula…
Mitral valve leakage, or mitral regurgitation (MR), is associated with heart failure symptoms including shortness of breath, fatigue, irregular heart rate. When…
Primary Objective - To determine if implantation of a permanent CRT pacing device (with LB-CRT, or conventional BiV-CRT with a coronary sinus LV lead) can impro…